Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sai Parenteral'sBOM:544742 +5.09%14 Current Ratio is 1.40 as of Sep. 2025, which is 22% above its 10-year median of 1.15. GuruFocus rates BOM:544742 with a GF Score™ of 14/100. The stock has 7 warning signs investors should review. Among 998 Drug Manufacturers companies, Sai Parenteral's ranks worse than 68.04% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Sai Parenteral's's current ratio for the quarter that ended in Sep. 2025 was 1.40.
Sai Parenteral's has a current ratio of 1.40. It generally indicates good short-term financial strength.
The historical rank and industry rank for Sai Parenteral's's Current Ratio or its related term are showing as below:
BOM:544742'
s Current Ratio Range Over the Past 10 Years
Min: 0.81 Med: 1.15 Max: 1.4
Current: 1.4
During the past 3 years, Sai Parenteral's's highest Current Ratio was 1.40. The lowest was 0.81. And the median was 1.15.
BOM:544742's Current Ratio is ranked worse than 68.04% of 998
companies
in the Drug Manufacturers industry
Industry Median: 1.97
vs BOM:544742: 1.40
Sai Parenteral's (BOM:544742) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Sai Parenteral's Current Ratio Related Terms
Sai Parenteral's Current Ratio Historical Data
* Premium members only.
The historical data trend for Sai Parenteral's's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sai Parenteral's Current Ratio Chart
Sai Parenteral's Annual Data
Trend
Mar23
Mar24
Mar25
Current Ratio
1.07
1.23
0.81
Sai Parenteral's Semi-Annual Data
Mar23
Mar24
Mar25
Sep25
Current Ratio
1.07
1.23
0.81
1.40
BOM:544742 vs LLY, JNJ, ABBV: Current Ratio Comparison
For the Drug Manufacturers - General subindustry, Sai Parenteral's's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sai Parenteral's Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sai Parenteral's's Current Ratio distribution charts can be found below:
* The bar in red indicates where Sai Parenteral's's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sai Parenteral's (BOM:544742) has a Current Ratio of 1.40 as of Sep. 2025. This is 22% above median its historical median of 1.15. Over the past decade, Sai Parenteral's' Current Ratio has ranged from 0.81 to 1.40. According to the industry distribution chart, Sai Parenteral's ranks #679 out of 998 companies in the Drug Manufacturers industry, placing it in the top 68%.
Is Sai Parenteral's' Current Ratio too high?
Sai Parenteral's' current Current Ratio of 1.40 is 22% above median its 10-year median of 1.15. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 1.40. The Drug Manufacturers industry median Current Ratio is 1.97. Sai Parenteral's' value of 1.40 is 28.9% below this industry median. Based on the distribution chart, Sai Parenteral's ranks #679 out of 998 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sai Parenteral's has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Sai Parenteral's' Current Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Sai Parenteral's ranks #679 out of 998 companies for Current Ratio. This places Sai Parenteral's in the lower half of its industry. The industry median Current Ratio is 1.97. Sai Parenteral's' value of 1.40 is 28.9% below this benchmark. Historically, Sai Parenteral's' own Current Ratio has ranged from 0.81 to 1.40 over the past decade. While the company's 10-year median is 1.15 vs. the industry median of 1.97, Sai Parenteral's has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 1.97, based on 998 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sai Parenteral's's current Current Ratio of 1.40 is 28.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 1.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sai Parenteral's's current Current Ratio is 1.40, which is 22% above median its own 10-year median of 1.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Parenteral's stock overvalued right now?
Sai Parenteral's (BOM:544742) has a current Current Ratio of 1.40. The current Current Ratio is 1.40, which is 22% above median its 10-year median of 1.15 and 28.9% below the Drug Manufacturers industry median of 1.97. Sai Parenteral's' overall GF Score™ is 14/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Sai Parenteral's (BOM:544742), the current Current Ratio is 1.40 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sai Parenteral's Ltd is a diversified pharmaceutical formulations company. Its business is organised in two verticals: (i) Branded Generic Formulations: Through the branded generics portfolio, it serves the domestic market with formulations across multiple therapeutic areas. and (ii) Contract Development and Manufacturing Organisation (CDMO): It provides CDMO services to pharmaceutical companies, supporting activities from product development to commercial manufacturing. Its product portfolio includes cardiovascular care, neuropsychiatry, anti-diabetic therapy, respiratory health, antibiotics, gastroenterology, vitamins, etc. The majority of the company's revenue is derived from the Branded Generic Formulations business.
14GF Score
Get the complete analysis for BOM:544742
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544742 has been successfully added to your 
